7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Cardiovascular Regenerative Medicine
The advancements in cardiovascular regenerative medicine are reshaping therapeutic strategies for heart diseases by promoting tissue repair and regeneration. This innovative field leverages technologies such as induced pluripotent stem cells and growth factor delivery to restore the heart’s structural and functional integrity. Bioengineered scaffolds and 3D bioprinting are also being utilized to reconstruct damaged myocardium and improve vascularization. Researchers are further exploring the role of exosomes and microRNAs in enhancing the heart’s natural regenerative processes. With ongoing clinical trials and interdisciplinary collaboration, cardiovascular regenerative medicine holds immense potential to provide long-term solutions for conditions like ischemic heart disease and heart failure, moving beyond traditional treatments toward curative approaches.
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Steve Cohen
Medvesta Hypnosis Healthcare, NSA Illinois, United States
Ruth Rasmussen
Liberty University, United States
Franz Porzsolt
Private Research Institute Clinical Economics, GermanySubmit your abstract Today
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Implantation of permanent cardiac pacemakers with right-sided access in collaboration with a vascular surgeon: pro et contra
Davor Horvat, General Hospital, , Croatia (Hrvatska)
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : MrgD as a Novel Modeling and Treatment Target for Pulmonary Hypertension
Panpan Hao, Department of Cardiology, Qilu Hospital, Shandong University, Jinan, Shandong, China